Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis

被引:12
作者
Song, Gwan Gyu [1 ]
Lee, Young Ho [1 ]
机构
[1] Korea Univ, Coll Med, Med Ctr, Div Rheumatol,Dept Internal Med, Seoul 136705, South Korea
关键词
Meta-analysis; ovarian cancer; polymorphism; Vitamin D receptor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENE POLYMORPHISMS; RISK; PREVENTION; CARCINOMA;
D O I
10.3109/08820139.2013.822881
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR = 1.094, 95% CI = 1.028-1.163, p = 0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR = 1.235, 95% CI = 1.019-1.497, p = 0.032 and OR = 1.287, 95% CI = 1.029-1.609, p = 0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele = 1.084, 95% CI = 0.936-1.255, p = 0.280, OR for the T allele = OR = 0.847, 95% CI = 0.706-1.270, p = 0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.
引用
收藏
页码:661 / 672
页数:12
相关论文
共 24 条
  • [1] Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk
    Ahn, Jiyoung
    Albanes, Demetrius
    Berndt, Sonja I.
    Peters, Ulrike
    Chatterjee, Nilanjan
    Freedman, Neal D.
    Abnet, Christian C.
    Huang, Wen-Yi
    Kibel, Adam S.
    Crawford, E. David
    Weinstein, Stephanie J.
    Chanock, Stephen J.
    Schatzkin, Arthur
    Hayes, Richard B.
    [J]. CARCINOGENESIS, 2009, 30 (05) : 769 - 776
  • [2] Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Clendenen, Tess V.
    Arslan, Alan A.
    Koenig, Karen L.
    Enquist, Kerstin
    Wirgin, Isaac
    Agren, Asa
    Lukanova, Annekatrin
    Sjodin, Hubert
    Zeleniuch-Jacquotte, Anne
    Shore, Roy E.
    Hallnians, Goran
    Toniolo, Paolo
    Lundin, Eva
    [J]. CANCER LETTERS, 2008, 260 (1-2) : 209 - 215
  • [3] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [4] Meta-analysis: Principles and procedures
    Egger, M
    Smith, GD
    Phillips, AN
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7121): : 1533 - 1537
  • [5] Bias in meta-analysis detected by a simple, graphical test
    Egger, M
    Smith, GD
    Schneider, M
    Minder, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109): : 629 - 634
  • [6] Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer
    Garland, Cedric F.
    Mohr, Sharif B.
    Gorham, Edward D.
    Grant, William B.
    Garland, Frank C.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 31 (06) : 512 - 514
  • [7] Quantifying heterogeneity in a meta-analysis
    Higgins, JPT
    Thompson, SG
    [J]. STATISTICS IN MEDICINE, 2002, 21 (11) : 1539 - 1558
  • [8] Vitamin D: Its role in cancer prevention and treatment
    Holick, Michael F.
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2006, 92 (01) : 49 - 59
  • [9] Ovarian Cancer: Etiology, Risk Factors, and Epidemiology
    Hunn, Jessica
    Rodriguez, Gustavo C.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01) : 3 - 23
  • [10] Köstner K, 2009, ANTICANCER RES, V29, P3511